Urolithiasis Biobank

Kidney stone disease affects approximately 10% of working age adults and carries a high risk of recurrence within five years of treatment. Associated hospital admissions have also been on the rise further encumbering services. It is in this context Oxford Biomedical Research Centre supported the creation of the UK’s first comprehensive kidney stone patient biobank.

Linked to clinical data the Urolithiasis Biobank enables the identification of biochemical risk factors in urine and blood, and supports research aiming to establish the aetiology of kidney stone disease. The collection now holds samples from over 480 kidney stone patients (Sep 2013).


To initiate the UK’s first comprehensive biobank for patients with kidney stone disease in order to facilitate world class translational research in the field of urolithiasis.

Cohort Description:

  • Established 2011.
  • Samples from over 480 kidney stone patients.
  • Sample formats = blood, stones.
  • Data Sets = demographics, clinical variables, drugs, family Hx etc
  • Recruitment = Open. Aim to recruit 150 patients per year.


External researchers may access the samples and related data, however use will only be granted after formal application.

Principal Investigator:

Dr Ben Turney.


Emily Grout, Research Nurse.